• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆内脂素作为终末期肾病血液透析患者心血管事件的预测指标

Plasma Endocan as a Predictor of Cardiovascular Event in Patients with End-Stage Renal Disease on Hemodialysis.

作者信息

Kim Jin Sug, Ko Gang Jee, Kim Yang Gyun, Lee So Young, Lee Dong Young, Jeong Kyung Hwan, Lee Sang Ho

机构信息

Division of Nephrology, Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul 02453, Korea.

Division of Nephrology, Department of Internal Medicine, Korea University College of Medicine, Seoul 02841, Korea.

出版信息

J Clin Med. 2020 Dec 18;9(12):4086. doi: 10.3390/jcm9124086.

DOI:10.3390/jcm9124086
PMID:33352837
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7766985/
Abstract

Endocan, a potential biomarker of endothelial dysfunction, is associated with increased cardiovascular risk. We investigated the utility of plasma endocan for predicting cardiovascular risk in end-stage renal disease (ESRD) patients undergoing hemodialysis. Of the 452 patients in the K-cohort, 354 with available plasma endocan levels were enrolled. The correlation between plasma endocan levels and the clinical characteristics of a study population were analyzed. We divided patients into two groups, according to plasma endocan levels, and investigated the predictive value of endocan for the occurrence of cardiovascular events. In a multiple linear regression analysis, plasma endocan levels were positively correlated with previous cardiovascular events and negatively correlated with body mass index, albumin, and triglyceride. Patients with higher plasma endocan levels experienced more frequent cardiovascular events than those with lower plasma endocan levels (12.9% in the lower group vs. 22.7% in the higher group, = 0.016). Cox proportional hazard models showed that higher plasma endocan levels were an independent predictor of cardiovascular events in ESRD patients on hemodialysis ((hazard ration) HR 1.949, 95% (confidence interval) CI 1.144-3.319, = 0.014). Our results suggest that plasma endocan level might be a useful biomarker for predicting cardiovascular events in ESRD patients on hemodialysis.

摘要

内脂素是一种内皮功能障碍的潜在生物标志物,与心血管风险增加有关。我们研究了血浆内脂素在预测接受血液透析的终末期肾病(ESRD)患者心血管风险方面的效用。在K队列的452名患者中,354名有可用血浆内脂素水平的患者被纳入研究。分析了血浆内脂素水平与研究人群临床特征之间的相关性。我们根据血浆内脂素水平将患者分为两组,并研究了内脂素对心血管事件发生的预测价值。在多元线性回归分析中,血浆内脂素水平与既往心血管事件呈正相关,与体重指数、白蛋白和甘油三酯呈负相关。血浆内脂素水平较高的患者比血浆内脂素水平较低的患者经历心血管事件的频率更高(较低组为12.9%,较高组为22.7%,P = 0.016)。Cox比例风险模型显示,较高的血浆内脂素水平是接受血液透析的ESRD患者心血管事件的独立预测因素(风险比HR 1.949,95%置信区间CI 1.144 - 3.319,P = 0.014)。我们的结果表明,血浆内脂素水平可能是预测接受血液透析的ESRD患者心血管事件的有用生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba2/7766985/7419f1855f2f/jcm-09-04086-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba2/7766985/7419f1855f2f/jcm-09-04086-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba2/7766985/7419f1855f2f/jcm-09-04086-g001.jpg

相似文献

1
Plasma Endocan as a Predictor of Cardiovascular Event in Patients with End-Stage Renal Disease on Hemodialysis.血浆内脂素作为终末期肾病血液透析患者心血管事件的预测指标
J Clin Med. 2020 Dec 18;9(12):4086. doi: 10.3390/jcm9124086.
2
Endocan as a Potential Marker for Predicting All-Cause Mortality in Hemodialysis Patients.内脂素作为预测血液透析患者全因死亡率的潜在标志物。
J Clin Med. 2023 Nov 30;12(23):7427. doi: 10.3390/jcm12237427.
3
Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease.血浆内皮细胞蛋白聚糖水平与慢性肾脏病中的炎症、血管异常、心血管事件和生存有关。
Kidney Int. 2014 Dec;86(6):1213-20. doi: 10.1038/ki.2014.227. Epub 2014 Jul 2.
4
Plasma endocan level and prognosis of immunoglobulin A nephropathy.血浆内脂素水平与IgA肾病的预后
Kidney Res Clin Pract. 2016 Sep;35(3):152-9. doi: 10.1016/j.krcp.2016.07.001. Epub 2016 Jul 14.
5
Serum endocan as a predictive biomarker of cardiovascular risk in erectile dysfunction patients.血清内脂素作为勃起功能障碍患者心血管风险的预测生物标志物。
Andrologia. 2018 Dec;50(10):e13113. doi: 10.1111/and.13113. Epub 2018 Jul 23.
6
Endocan: a novel predictor of endothelial dysfunction in obstructive sleep apnea syndrome.内脂素:阻塞性睡眠呼吸暂停综合征中内皮功能障碍的一种新型预测指标。
Clin Respir J. 2018 Jan;12(1):84-90. doi: 10.1111/crj.12487. Epub 2016 May 24.
7
Serum Endocan Levels are Associated With Paraoxonase 1 Concentration in Patients With Chronic Kidney Disease.慢性肾脏病患者血清内脂素水平与对氧磷酶1浓度相关。
Ther Apher Dial. 2018 Aug;22(4):325-331. doi: 10.1111/1744-9987.12654. Epub 2018 Jan 25.
8
Levels of endothelial cell-specific molecule-1 (ESM-1) in overt hypothyroidisim.显性甲状腺功能减退症中内皮细胞特异性分子-1(ESM-1)的水平。
Endocr Res. 2016 Nov;41(4):275-280. doi: 10.3109/07435800.2015.1135443. Epub 2016 Feb 23.
9
Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome.内脂素是多囊卵巢综合征女性心血管风险增加的一个预测指标。
Endocr Res. 2017 May;42(2):145-153. doi: 10.1080/07435800.2016.1255896. Epub 2016 Dec 2.
10
Plasma Endocan as a Biomarker of Thrombotic Events in COVID-19 Patients.血浆内脂素作为新冠病毒肺炎患者血栓形成事件的生物标志物
J Clin Med. 2022 Sep 22;11(19):5560. doi: 10.3390/jcm11195560.

引用本文的文献

1
Serum Endocan as a Predictor of Survival and Cardiovascular Events in Patients Without Diabetic Kidney Disease on Chronic Haemodialysis: A Prospective, Observational Study.血清内脂素作为慢性血液透析中无糖尿病肾病患者生存及心血管事件预测指标的前瞻性观察研究
Medicina (Kaunas). 2025 May 27;61(6):991. doi: 10.3390/medicina61060991.
2
Serum Endocan Levels as a Risk Factor for Peripheral Artery Disease in Non-Dialysis Patients with Chronic Kidney Disease Stages 3-5.血清内脂素水平作为3-5期慢性肾脏病非透析患者外周动脉疾病的危险因素
Medicina (Kaunas). 2025 Mar 24;61(4):577. doi: 10.3390/medicina61040577.
3
Longitudinal analysis of SARS-CoV-2 IgG antibody durability in Puerto Rico.

本文引用的文献

1
Endocan: A novel biomarker for risk stratification, prognosis and therapeutic monitoring in human cardiovascular and renal diseases.内脂素:人类心血管和肾脏疾病风险分层、预后及治疗监测的新型生物标志物。
Clin Chim Acta. 2020 Oct;509:310-335. doi: 10.1016/j.cca.2020.07.041. Epub 2020 Jul 22.
2
Effects of online hemodiafiltration on anemia and nutritional status in chronic hemodialysis patients.在线血液透析滤过对慢性血液透析患者贫血及营养状况的影响。
Kidney Res Clin Pract. 2020 Mar 31;39(1):103-111. doi: 10.23876/j.krcp.19.082.
3
Circulating PCSK9 Level and Risk of Cardiovascular Events and Death in Hemodialysis Patients.
波多黎各SARS-CoV-2 IgG抗体持久性的纵向分析。
Sci Rep. 2024 Dec 28;14(1):30743. doi: 10.1038/s41598-024-80465-4.
4
Serum Endocan Is a Risk Factor for Aortic Stiffness in Patients Undergoing Maintenance Hemodialysis.血清内皮细胞蛋白聚糖是维持性血液透析患者主动脉僵硬的危险因素。
Medicina (Kaunas). 2024 Jun 14;60(6):984. doi: 10.3390/medicina60060984.
5
Endocan as a Potential Marker for Predicting All-Cause Mortality in Hemodialysis Patients.内脂素作为预测血液透析患者全因死亡率的潜在标志物。
J Clin Med. 2023 Nov 30;12(23):7427. doi: 10.3390/jcm12237427.
6
High circulating endocan in chronic kidney disease? A systematic review and meta-analysis.慢性肾脏病中循环内Endocan 水平升高?系统评价和荟萃分析。
PLoS One. 2023 Aug 9;18(8):e0289710. doi: 10.1371/journal.pone.0289710. eCollection 2023.
7
Endocan in prediabetes, diabetes, and diabetes-related complications: a systematic review and meta-analysis.内皮抑素在糖尿病前期、糖尿病及糖尿病相关并发症中的作用:一项系统综述与荟萃分析。
Diabetol Metab Syndr. 2023 May 16;15(1):102. doi: 10.1186/s13098-023-01076-z.
8
Elevated Circulating Endocan Levels Are Associated with Increased Levels of Endothelial and Inflammation Factors in Postprandial Lipemia.餐后血脂异常时循环血中内卡蛋白水平升高与内皮细胞及炎症因子水平增加有关。
J Clin Med. 2023 Feb 6;12(4):1267. doi: 10.3390/jcm12041267.
血液透析患者循环中前蛋白转化酶枯草溶菌素9水平与心血管事件及死亡风险
J Clin Med. 2020 Jan 17;9(1):244. doi: 10.3390/jcm9010244.
4
Relationship between Plasma Endocan Level and Clinical Outcome of Chinese Peritoneal Dialysis Patients.血浆内皮素水平与中国腹膜透析患者临床结局的关系。
Kidney Blood Press Res. 2019;44(5):1259-1270. doi: 10.1159/000502961. Epub 2019 Oct 4.
5
Serum endocan levels, carotid intima-media thickness and microalbuminuria in patients with newly diagnosed hypertension.血清内皮细胞黏附分子水平、颈动脉内膜中层厚度和新诊断高血压患者的微量白蛋白尿。
Clin Exp Hypertens. 2019;41(8):787-794. doi: 10.1080/10641963.2019.1652632. Epub 2019 Aug 7.
6
Increase of endocan, a new marker for inflammation and endothelial dysfunction, in acute kidney injury.新型炎症和内皮功能障碍标志物内皮糖蛋白在急性肾损伤中的升高。
North Clin Istanb. 2018 Sep 6;6(2):124-128. doi: 10.14744/nci.2018.70446. eCollection 2019.
7
Endocan as a marker of microvascular inflammation in kidney transplant recipients.内皮细胞作为肾移植受者微血管炎症的标志物。
Sci Rep. 2019 Feb 12;9(1):1854. doi: 10.1038/s41598-018-37975-9.
8
The higher serum endocan levels may be a risk factor for the onset of cardiovascular disease: A meta-analysis.血清内配蛋白水平升高可能是心血管疾病发病的一个危险因素:一项荟萃分析。
Medicine (Baltimore). 2018 Dec;97(49):e13407. doi: 10.1097/MD.0000000000013407.
9
Serum Endocan Levels are Associated With Paraoxonase 1 Concentration in Patients With Chronic Kidney Disease.慢性肾脏病患者血清内脂素水平与对氧磷酶1浓度相关。
Ther Apher Dial. 2018 Aug;22(4):325-331. doi: 10.1111/1744-9987.12654. Epub 2018 Jan 25.
10
Biomarkers of Endothelial, Renal, and Platelet Dysfunction in Stage 5 Chronic Kidney Disease Hemodialysis Patients With Heart Failure.5期慢性肾脏病心力衰竭血液透析患者内皮、肾脏及血小板功能障碍的生物标志物
Clin Appl Thromb Hemost. 2018 Mar;24(2):235-240. doi: 10.1177/1076029617729216. Epub 2017 Oct 8.